Last Updated:2025/11/24
Sentence
第II相試験では、その治験薬(神経系を標的とするモノクローナル抗体)が神経組織に選択的に結合し、神経障害性疼痛を軽減しました。
Quizzes for review
During the phase II trial, the experimental drug mAb-ner-01 demonstrated selective binding to neural tissue and alleviated neuropathic pain.
See correct answer
During the phase II trial, the experimental drug mAb-ner-01 demonstrated selective binding to neural tissue and alleviated neuropathic pain.
音声機能が動作しない場合はこちらをご確認ください
Related words
Word Edit Setting
- Users who have edit permission for words - All Users
- Screen new word creation
- Screen word edits
- Screen word deletion
- Screen the creation of new headword that may be duplicates
- Screen changing entry name
- Users authorized to vote on judging - Editor
- Number of votes required for decision - 1
Sentence Edit Setting
- Users who have edit permission for sentences - All Users
- Screen sentence deletion
- Users authorized to vote on judging - Editor
- Number of votes required for decision - 1
Quiz Edit Setting
- Users who have edit permission for quizzes - All Users
- Users authorized to vote on judging - Editor
- Number of votes required for decision - 1
